Highmark Health’s VITAL Program to Evaluate Avinger’s Novel Treatment for Peripheral Artery Disease
27 juin 2016 16h01 HE
|
Avinger Inc
PITTSBURGH and REDWOOD CITY, Calif., June 27, 2016 (GLOBE NEWSWIRE) -- Highmark Health, Allegheny Health Network (AHN) and Avinger, Inc. (NASDAQ:AVGR) announced a collaboration today to evaluate...
Avinger, Inc. Announces Drawdown of $10 Million Under Term Loan Facility with CRG
15 juin 2016 16h01 HE
|
Avinger Inc
REDWOOD CITY, Calif., June 15, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that it has...
Avinger, Inc. Announces First Quarter 2016 Results
04 mai 2016 16h01 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., May 04, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the...
Avinger, Inc. to Announce First Quarter 2016 Results on Wednesday, May 4, 2016
27 avr. 2016 16h01 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., April 27, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
Avinger, Inc. Announces Fourth Quarter and Full Year 2015 Results
01 mars 2016 16h05 HE
|
Avinger, Inc.
Pantheris™ Commercial Launch Underway REDWOOD CITY, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral...
Avinger Announces FDA Clearance and U.S. Launch of Breakthrough Treatment for Patients With Peripheral Artery Disease
01 mars 2016 16h03 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the...
Avinger, Inc. to Present Cowen and Company 36th Annual Health Care Conference
23 févr. 2016 16h05 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Feb. 23, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...
Avinger, Inc. to Announce Fourth Quarter and Year-End 2015 Results on Tuesday, March 1, 2016
18 févr. 2016 08h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...
Avinger, Inc. Names Joseph Rafferty as Vice President of Sales
04 janv. 2016 16h03 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Jan. 04, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...
Avinger Announces Filing of 510(k) Application for Enhanced Version of Pantheris(TM)
01 déc. 2015 16h25 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (NASDAQ:AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial...